Dealing with mental health conditions like depression can be challenging. Some people struggle to find the right treatment or combination of treatments for their condition. In major depression ...

Following a negative FDA advisory committee vote earlier this year, the other shoe has dropped for Lundbeck and Otsuka Pharmaceutical’s post-traumatic stress disorder (PTSD) hopeful. The FDA has ...

Agitation and aggression are challenging behaviors that can happen in people with dementia, especially in Alzheimer’s disease. It can cause you or your relative to act out in different ways. You may ...

A new drug to treat schizophrenia and depression has been approved by the U.S. Food and Drug Administration. Rexulti (brexpiprazole) tablets can be used to treat adults with schizophrenia. The new ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Poster data presented here at Psych Congress indicated three dosages of Rexulti improved ...

Otsuka and Lundbeck’s antidepressant Rexulti should be approved to treat Alzheimer’s disease-related agitation (AAD), according to FDA advisors – a move that could unlock a sizeable new market for the ...

(RTTNews) - The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.

The FDA issued a CRL for Rexulti's sNDA, citing insufficient evidence of effectiveness for PTSD treatment in combination with sertraline. The Psychopharmacologic Drugs Advisory Committee voted 1-10 ...

Credit: Getty Images. Brexpiprazole is an atypical antipsychotic. The Food and Drug Administration (FDA) has approved Rexulti ® (brexpiprazole) for the treatment of agitation associated with dementia ...

The approval was based on data from an ongoing phase 3 trial evaluating the safety and tolerability of brexpiprazole as maintenance treatment of 194 patients aged 13 to 17 years with schizophrenia.

This notice was approved by the Superior Court of Québec. Please read it carefully as it may affect your legal rights. MONTREAL, Aug. 23, 2025 /CNW/ - A proposed Settlement has been reached on behalf ...